168 related articles for article (PubMed ID: 3511405)
1. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Teychenne PF; Bergsrud D; Elton RL; Racy A
Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine: low-dose therapy in Parkinson disease.
Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
[TBL] [Abstract][Full Text] [Related]
4. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
6. Low-dose bromocriptine therapy in severe Parkinson's disease.
Devathasan G; Chong PN; Puvanendran K; Lun KC; Wong PK
Clin Neuropharmacol; 1984; 7(3):231-7. PubMed ID: 6386152
[TBL] [Abstract][Full Text] [Related]
7. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Riopelle RJ; Gawel MJ; Libman I; King DB; McLean DR; Paulseth R; Raphy B; Bouchard S
Eur Neurol; 1988; 28 Suppl 1():11-4. PubMed ID: 3288477
[TBL] [Abstract][Full Text] [Related]
8. Low-dose bromocriptine in the early phases of Parkinson's disease.
Tolosa E; Blesa R; Bayes A; Forcadell F
Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R
Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
Guttman M
Neurology; 1997 Oct; 49(4):1060-5. PubMed ID: 9339690
[TBL] [Abstract][Full Text] [Related]
11. A multi-center, double-blind study on slow-release bromocriptine in the treatment of Parkinson's disease.
Mannen T; Mizuno Y; Iwata M; Goto I; Kanazawa I; Kowa H; Nishitani H; Ogawa N; Takahashi A; Tashiro K
Neurology; 1991 Oct; 41(10):1598-602. PubMed ID: 1922801
[TBL] [Abstract][Full Text] [Related]
12. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
LeWitt PA; Gopinathan G; Ward CD; Sanes JN; Dambrosia JM; Durso R; Calne DB
Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group.
J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):77-82. PubMed ID: 2651567
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Gawel M; Riopelle R; Libman I; Bouchard S
Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
[No Abstract] [Full Text] [Related]
15. The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
Hely MA; Morris JG; Rail D; Reid WG; O'Sullivan DJ; Williamson PM; Genge S; Broe GA
J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):324-8. PubMed ID: 2647907
[TBL] [Abstract][Full Text] [Related]
16. Low-dose bromocriptine therapy in Parkinson's disease.
Pfeiffer RF; Wilken K; Glaeske C; Lorenzo AS
Arch Neurol; 1985 Jun; 42(6):586-8. PubMed ID: 4004603
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of bromocriptine in the treatment of Parkinson's disease.
Mackenzie RA; Lance JW
Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
[TBL] [Abstract][Full Text] [Related]
18. The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
Selby G
Clin Exp Neurol; 1989; 26():129-39. PubMed ID: 2701877
[TBL] [Abstract][Full Text] [Related]
19. Effects of bromocriptine on parkinsonism. A nation-wide collaborative double-blind study.
Toyokura Y; Mizuno Y; Kase M; Sobue I; Kuroiwa Y; Narabayashi H; Uono M; Nakanishi T; Kameyama M; Ito H
Acta Neurol Scand; 1985 Aug; 72(2):157-70. PubMed ID: 3901650
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine combined with levodopa in Parkinson's disease.
Gauthier G; Martins da Silva A
Eur Neurol; 1982; 21(4):217-26. PubMed ID: 7117308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
